The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies
Abstract
PURPOSE: To evaluate the response, time to progression, survival, and impact of radiation (RT) dose on survival in patients with intrahepatic malignancies treated on a phase I trial of escalated focal liver RT. PATIENTS AND METHODS: From April 1996 to January 1998, 43 patients with unresectable intrahepatic hepatobiliary cancer (HB; 27 patients) and colorectal liver metastases (LM; 16 patients) were treated with high-dose conformal RT. The median tumor size was 10 × 10 × 8 cm. The median RT dose was 58.5 Gy (range, 28.5 to 90 Gy), 1.5 Gy twice daily, with concurrent continuous-infusion hepatic arterial fluorodeoxyuridine (0.2 mg/kg/d) during the first 4 weeks of RT. RESULTS: The response rate in 25 assessable patients was 68% (16 partial and one complete response). With a median potential follow-up period of 26.5 months, the median times to progression for all tumors, LM, and HB were 6, 8, and 3 months, respectively. The median survival times of all patients, patients with LM, and patients with HB were 16, 18, and 11 months, respectively. On multivariate analyses, escalated RT dose was independently associated with improved progression-free and overall survival. The median survival of patients treated with 70 Gy or more has not yet been reached (16.4+ months), compared with 11.6 months in patients treated with lower RT doses (P = .0003). CONCLUSION: The excellent response rate, prolonged intrahepatic control, and improved survival in patients treated with RT doses of 70 Gy or more motivate continuation of dose-escalation studies for patients with intrahepatic malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Rougier, P., Van Cutsem, E., Bajetta, E., Niederle, N., Possinger, K., Labianca, R., Navarro, M., Morant, R., Bleiberg, H., Wils, J., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03085-2 · Cited by 992
The use of active breathing control (ABC) to reduce margin for breathing motion
Wong, J. W., Sharpe, M. B., Jaffray, D. A., Kini, V. R., Robertson, J. M., Stromberg, J. S., & Martinez, A. A. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00056-5 · Cited by 912
Blomgren, H., Lax, I., Näslund, I., & Svanström, R. (1995) · Acta Oncologica · doi:10.3109/02841869509127197 · Cited by 846
(1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321903 · Cited by 809
Hughes, K. S., Simon, R., Songhorabodi, S., et al. (1986) · PubMed · Cited by 765
Hughes, K. S., Rosenstein, R. B., Songhorabodi, S., Adson, M. A., Ilstrup, D. M., Fortner, J. G., Maclean, B. J., Foster, J. H., Daly, J. M., Fitzherbert, D., et al. (1988) · Diseases of the Colon & Rectum · doi:10.1007/bf02552560 · Cited by 383
The use of 3-D dose volume analysis to predict radiation hepatitis
Lawrence, T. S., Ten Haken, R. K., Kessler, M. L., Robertson, J. M., Lyman, J. T., Lavigne, M. L., Brown, M. B., Duross, D. J. M. A., Andrews, J. C., Ensminger, W. D., et al. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90651-w · Cited by 296
Self-citationRaoul, J., Guyader, D., Bretagne, J., Heautot, J., Duvauferrier, R., Bourguet, P., Bekhechi, D., Deugnier, Y. M., & Gosselin, M. (1997) · Hepatology · doi:10.1002/hep.510260511 · Cited by 286
The use of 3-D dose volume analysis to predict radiation hepatitis
Lawrence, T. S., Kessler, M. L., Lavigne, M. L., Lyman, J. T., & Ten Haken, R. K. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90564-k · Cited by 275
Self-citationTreatment of hepatocellular carcinoma: too many options?
Venook, A. P. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1323 · Cited by 199
Radiofrequency thermal ablation of liver tumors
Rhim, H., & Dodd, G. D. (1999) · Journal of Clinical Ultrasound · doi:10.1002/(sici)1097-0096(199906)27:5<221::aid-jcu1>3.0.co;2-t · Cited by 173
McGinn, C. J., Ten Haken, R. K., Ensminger, W. D., Walker, S., Wang, S., & Lawrence, T. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2246 · Cited by 164
Self-citationUse of Veff and iso-NTCP in the implementation of dose escalation protocols
Haken, R. K. T., Martel, M. K., Kessler, M. L., Hazuka, M. B., Lawrence, T. S., Robertson, J. M., Turrisi, A. T., & Lichter, A. S. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90398-f · Cited by 103
Self-citationO'Connell, M. J., Nagorney, D. M., Bernath, A. M., Schroeder, G. S., Fitzgibbons, R. J., Mailliard, J. A., Burch, P. A., Bolton, J. S., Colón‐Otero, G., & Krook, J. E. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2528 · Cited by 63
Ychou, M., Pèlegrin, A., Faurous, P., Robert, B., Saccavini, J.-C., Guerreau, D., Rossi, J., Fabbro, M., Buchegger, F., Mach, J., et al. (1998) · International Journal of Cancer · Cited by 57
Findlay, M. P. N., Hill, A., Cunningham, D., Norman, A. R., Nicolson, M. C., Ford, H. E. R., Husband, J. E., Evans, C., & Carter, R. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058800 · Cited by 24
Cited by
Analysis of radiation-induced liver disease using the Lyman NTCP model
Dawson, L. A., Normolle, D., Balter, J. M., McGinn, C. J., Lawrence, T. S., & Ten Haken, R. K. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02846-8 · Cited by 767
Self-citationKennedy, A., Nag, S., Salem, R., Murthy, R., McEwan, A. J., Nutting, C., Benson, A., Espat, J., Bilbao, J. I., Sharma, R. A., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.060 · Cited by 676
Tse, R. V., Hawkins, M., Lockwood, G., Kim, J. J., Cummings, B., Knox, J., Sherman, M., & Dawson, L. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3529 · Cited by 589
Self-citationMéndez Romero, A., Wunderink, W., Hussain, S. M., De Pooter, J. A., Heijmen, B. J. M., Nowak, P. C. J. M., Nuyttens, J. J., Brandwijk, R. P., Verhoef, C., Ijzermans, J. N. M., et al. (2006) · Acta Oncologica · doi:10.1080/02841860600897934 · Cited by 498
Stereotactic body radiation therapy: a novel treatment modality
Lo, S. S., Fakiris, A. J., Chang, E. L., Mayr, N. A., Wang, J. Z., Papiez, L., Teh, B. S., McGarry, R. C., Cardenes, H. R., & Timmerman, R. D. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.188 · Cited by 419
Metadata
- Authors
- Dawson, L. A., McGinn, C. J., Normolle, D., Ten Haken, R. K., Walker, S., Ensminger, W., & Lawrence, T. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-06-11
- Volume
- 18
- Issue
- 11
- Pages
- 2210-2218
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2242188005
- Cited by
- 395
- References
- 17
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.